BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6460884)

  • 1. [Laboratory and clinical studies on cefsulodin (author's transl)].
    Kumasaka Y; Nakahata H; Endo K; Sasaki K; Matsuhashi A; Narita S; Imamura K; Takebe K; Masaki N; Tamura T
    Jpn J Antibiot; 1981 Oct; 34(10):1416-21. PubMed ID: 6460884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical application of cefsulodin to Pseudomonas aeruginosa infections in the surgical field (author's transl)].
    Tanimura H; Mukaihara S; Hikasa Y; Hajiro A; Takenada M; Maki Y; Nakajima K; Henmi K; Nio Y; Kikuchi S; Hamagaki H; Sugimoto S; Kobayashi M; Matsukawa Y; Masuda K; Yasumoto H; Usui H
    Jpn J Antibiot; 1981 Apr; 34(4):459-65. PubMed ID: 7289036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical studies on cefsulodin in the field of pediatrics].
    Yanagisawa K; Yanagisawa K; Hoshina H; Ichihashi H
    Jpn J Antibiot; 1982 Nov; 35(11):2683-7. PubMed ID: 6820393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical evaluation of cefsulodin in Pseudomonas infections in children].
    Meguro H; Ozawa S; Koike Y; Hiraiwa M; Hashimoto G; Hashira S; Fujii R; Takahashi A
    Jpn J Antibiot; 1982 Nov; 35(11):2639-51. PubMed ID: 7169664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative activity of cefsulodin on Pseudomonas aeruginosa, Acinetobacter and Enterobacteriaceae (author's transl)].
    Courtieu AL; Drugeon HB; Bryskier A; Chung SS; Reynaud A
    Pathol Biol (Paris); 1982 Jun; 30(6):432-9. PubMed ID: 6810287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ["In vitro" activity of a new cephalosporin (CGP-7174-E or cefsulodin) against "Pseudomonas aeruginosa" (author's transl)].
    Berche P; Descamps P; Avril JL; VĂ©ron M
    Ann Microbiol (Paris); 1979; 130B(4):477-84. PubMed ID: 120122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the in vitro activity of new beta-lactams and aminoglycosides against clinical isolates of Pseudomonas aeruginosa.
    Patzer J; Gieburowska R; Dzierzanowska D
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Oct; 253(1):110-20. PubMed ID: 6817544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gentamicin and cefsulodin efficacy in a rat abscess model.
    Rubinstein E; Dreznik Z; Mark Z
    Surg Gynecol Obstet; 1982 Sep; 155(3):363-8. PubMed ID: 6810484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriological studies with cefsulodin (CGP 7174/E), the first antipseudomonal cephalosporin.
    Ullmann U
    J Antimicrob Chemother; 1979 Sep; 5(5):563-7. PubMed ID: 115832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The experimental and clinical studies on cefsulodin in the pediatric field].
    Akita H; Iwata S; Iwasaki Y; Kanemitsu T; Hattori H; Jozaki K; Hotta M; Yamashita N; Nanri S; Sunagawa K; Iwata T; Osano M; Ichihashi Y
    Jpn J Antibiot; 1982 Nov; 35(11):2652-6. PubMed ID: 7169665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cefsulodin, a new antibiotic of the group of cephalosporins: its action on Pseudomonas aeruginosa (author's transl)].
    Segura C; Foz A; Fuster C; Tirado M; Roy C
    Med Clin (Barc); 1981 Jun; 77(2):50-5. PubMed ID: 6798336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Susceptibility of Pseudomonas aeruginosa recently isolated from clinical specimens to various antimicrobial agents and changes of susceptibility to carbenicillin, gentamicin and amikacin (author's transl)].
    Kosakai N; Oguri T
    Jpn J Antibiot; 1980 Jun; 33(6):668-74. PubMed ID: 6779031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental and clinical evaluation of cefsulodin in the pediatric field].
    Nishimura T; Takashima T; Hiromatsu K; Tabuki K
    Jpn J Antibiot; 1982 Nov; 35(11):2699-707. PubMed ID: 6820395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study of cefsulodin on Pseudomonas aeruginosa infections in otorhinolaryngology].
    Makishima K; Nakashima T; Toriya Y; Murata Y; Watanabe H; Kannae S
    Jpn J Antibiot; 1982 Dec; 35(12):2835-8. PubMed ID: 7182538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro studies with piperacillin. Effectiveness against enterobacteriaceae and pseudomonas aeruginosa compared to other antibiotics (author's transl)].
    Baier R; Puppel H
    Med Klin; 1979 Dec; 74(50):1923-7. PubMed ID: 120489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefsulodin: antibacterial activity and tentative interpretive zone standards for the disk susceptibility test.
    Barry AL; Jones RN; Thornsberry C
    Antimicrob Agents Chemother; 1981 Oct; 20(4):525-9. PubMed ID: 6211134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of in vitro bacteriostatic effect of five betalactamins against Pseudomonas aeruginosa (author's transl)].
    Lesage D; Delisle-Mizon F; Denis C; Vergez P; Daguet GL
    Pathol Biol (Paris); 1982 Jun; 30(6):440-3. PubMed ID: 6213917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Double-blind comparative clinical study of cefpiramide (SM-1652) and cefsulodin on complicated urinary tract infections due to P. aeruginosa].
    Kawamura N; Ohkoshi M; Okada K; Kumamoto Y; Miyamoto S; Niijima T; Kishi Y; Nishimura Y; Saito I; Yuge J
    Hinyokika Kiyo; 1983 Sep; 29(9):1147-88. PubMed ID: 6375316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of the inoculum effect on the MIC and MBC of 5 beta-lactams against Pseudomonas aeruginosa].
    Croize J; Le Noc P; Robert J
    Pathol Biol (Paris); 1984 May; 32(5):412-4. PubMed ID: 6429613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vivo-acquired resistance to cefsulodin by a strain of Pseudomonas aeruginosa].
    Jouvenot M; Michel-Briand Y; Dupont MJ; Cattin J
    Pathol Biol (Paris); 1984 May; 32(5):426-8. PubMed ID: 6429615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.